Uterine Fibroid Intervention and Gynecological Health Treatment Act of 2025

Download PDF
Bill ID: 119/s/2531
Last Updated: September 14, 2026

Sponsored by

Sen. Alsobrooks, Angela D. [D-MD]

ID: A000382

Follow the money

The bill

Uterine Fibroid Intervention and Gynecological Health Treatment Act of 2025

S. 2531, 119th Congress — read as touching Hospitals & Health Systems.

The sponsor

Sen. Alsobrooks, Angela D. [D-MD]

Every bill has someone who introduced it. That name is where the paper trail starts.

The money

$82,760 raised

27 itemised contributions to this sponsor, pulled from FEC filings.

The alignment

55% match to Project 2025

This bill's text tracks the "Department of Health and Human Services" section, p. 533-535 of the Mandate for Leadership.

Bill's Journey to Becoming a Law

Track this bill's progress through the legislative process

Latest Action

Committee on Health, Education, Labor, and Pensions. Hearings held.

March 18, 2026

Introduced

Committee Review

📍 Current Status

Next: The bill moves to the floor for full chamber debate and voting.

🗳️

Floor Action

✅

Passed Senate

🏛️

House Review

🎉

Passed Congress

🖊️

Presidential Action

⚖️

Became Law

📚 How does a bill become a law?

1. Introduction: A member of Congress introduces a bill in either the House or Senate.

2. Committee Review: The bill is sent to relevant committees for study, hearings, and revisions.

3. Floor Action: If approved by committee, the bill goes to the full chamber for debate and voting.

4. Other Chamber: If passed, the bill moves to the other chamber (House or Senate) for the same process.

5. Conference: If both chambers pass different versions, a conference committee reconciles the differences.

6. Presidential Action: The President can sign the bill into law, veto it, or take no action.

7. Became Law: If signed (or if Congress overrides a veto), the bill becomes law!

Bill Summary

Another bill from our esteemed leaders, because what the country really needs is more legislation and less actual problem-solving. Let's dissect this mess.

**Main Purpose & Objectives:** The Uterine Fibroid Intervention and Gynecological Health Treatment Act of 2025 (UFIGHT) claims to aim at increasing early detection and intervention for uterine fibroids, a condition that affects millions of women worldwide. How noble. In reality, it's just another excuse for politicians to pretend they care about women's health while lining the pockets of their pharma buddies.

**Key Provisions & Changes to Existing Law:** The bill authorizes the Secretary of Health and Human Services (HHS) to award grants for research on early detection and intervention strategies. It also allows states to use these grants for screening procedures, patient navigation services, and implementing evidence-based strategies. Oh, and let's not forget the obligatory "public awareness and education campaigns" – because what women really need is more pamphlets and PSAs telling them how to take care of their own bodies.

**Affected Parties & Stakeholders:** Women with uterine fibroids (the supposed beneficiaries), pharmaceutical companies (who will likely profit from increased screenings and treatments), medical device manufacturers (who'll sell more equipment for those fancy "advanced gynecological imaging" procedures), and, of course, the politicians who sponsored this bill (Ms. Alsobrooks and Ms. Lummis). Don't worry, they'll all be just fine.

**Potential Impact & Implications:** This bill is a classic case of "throwing money at a problem without actually solving it." The real impact will be on the wallets of taxpayers, who'll foot the bill for these grants and research initiatives. Meanwhile, pharmaceutical companies will reap the benefits of increased sales, and medical device manufacturers will cash in on the new equipment needed for those fancy screenings.

In short, this bill is a masterclass in legislative theater: it looks good on paper, but in reality, it's just another example of our politicians' incompetence and willingness to prioritize special interests over actual problem-solving. It's like they're trying to treat a symptom without addressing the underlying disease – which, in this case, is their own ineptitude.

Diagnosis: Legislative Fibroid (a rare condition where politicians pretend to care about women's health while actually serving their corporate masters). Prognosis: More of the same old bureaucratic nonsense. Treatment: A healthy dose of skepticism and a strong stomach for the inevitable waste of taxpayer dollars.

Related Topics

Public Health & Pandemic Response
Generated using Llama 3.1 70B (Dr. Haus personality)

💰 Campaign Finance Network

Sen. Alsobrooks, Angela D. [D-MD]

Congress 119 • 2024 Election Cycle

Total Contributions
$82,760
27 donors
PACs
$0
Organizations
$9,350
Committees
$0
Individuals
$72,550

No PAC contributions found

1
CHEROKEE NATION
1 transaction
$3,300
2
LAKEWOOD HEALTHCARE ASSOC LLC
1 transaction
$3,300
3
TYSON PROJECT MANAGEMENT GROUP LLC
1 transaction
$2,500
4
MASTER PRODUCTIONS, LLC.
1 transaction
$250

No committee contributions found

1
ADOLPH, GWENDOLYN
1 transaction
$6,600
2
THOMAS, TORI
1 transaction
$5,800
3
JAMAR, STEVEN
1 transaction
$3,700
4
WILLIAMS, ELIZABETH
1 transaction
$3,550
5
HAMMERSCHLAG, ALAN
1 transaction
$3,400
6
ABRAMSON, ANNE
1 transaction
$3,300
7
BARRY, JOHN
1 transaction
$3,300
8
SULLIVAN, ANNE
1 transaction
$3,300
9
BOLES, HOWARD
1 transaction
$3,300
10
BUTTON, LINDA K.
1 transaction
$3,300
11
BUTTON, KENNETH R.
1 transaction
$3,300
12
CAIN, VICKI
1 transaction
$3,300
13
COHEN, JANET
1 transaction
$3,300
14
COLOMBEL, ERIC
1 transaction
$3,300
15
CONVERSE, ROBERT E
1 transaction
$3,300
16
CONVERSE, MARILYN
1 transaction
$3,300
17
DESJARDINS, DAVID
1 transaction
$3,300
18
DONHAM, CHRISTOPHER
1 transaction
$3,300
19
FINLEY, SHANNON
1 transaction
$3,300
20
GENET, BENJAMIN
1 transaction
$3,300

Cosponsors & Their Campaign Finance

This bill has 4 cosponsors. Below are their top campaign contributors.

Sen. Lummis, Cynthia M. [R-WY]

ID: L000571

Top Contributors

20

1
HEGYI, ALBERT P
1ST FINANCIAL BANK USA • BANKER
IndividualNEW YORK, NY
$6,600
Dec 6, 2023
2
MANDELBLATT, DANIELLE
RETIRED • RETIRED
IndividualASPEN, CO
$6,600
Sep 26, 2024
3
MANDELBLATT, ERIC
SOROBAN CAPITAL PARTNERS LP • MANAGING PARTNER
IndividualASPEN, CO
$6,600
Sep 26, 2024
4
SAMANI, PYAHM
IndividualAUSTIN, TX
$5,800
Aug 8, 2023
5
CASCARILLA, MARISSA
NA • HOMEMAKER
IndividualMIAMI, FL
$3,700
Apr 1, 2024
6
CASCARILLA, CHARLES
PAXOS • CEO
IndividualMIAMI, FL
$3,700
Apr 1, 2024
7
DOWNS, RAISSA
TARPLIN, DOWNS AND YOUNG, LLC • CONSULTANT
IndividualWASHINGTON, DC
$3,600
Dec 12, 2024
8
SCARAMUCCI, ANTHONY
SKYBRIDGE • MANAGING PARTNER
IndividualPLANDOME, NY
$3,435
Jul 30, 2024
9
HOBART, ROBERT
VENTURE GOVERNMENT STRATEGIES • CONSULTANT
IndividualNASHVILLE, TN
$3,435
Aug 5, 2024
10
HOLDING, KATHLEEN MS.
SUNLIGHT RANCH CO. • EXECUTIVE
IndividualDAYTON, WY
$3,300
Dec 6, 2023

Sen. Marshall, Roger [R-KS]

ID: M001198

Top Contributors

24

1
THE KROGER CO. POLITICAL ACTION COMMITTEE
PACCINCINNATI, OH
$3,000
Mar 16, 2023
2
THE KROGER CO. POLITICAL ACTION COMMITTEE
PACCINCINNATI, OH
$2,500
Mar 23, 2023
3
INTERNATIONAL ASSOCIATION OF FIRE FIGHTERS
PACWASHINGTON, DC
$2,500
Mar 31, 2023
4
THE POLITICAL ACTION COMMITTEE OF THE FERTILIZER INSTITUTE
PACWASHINGTON, DC
$1,500
Mar 31, 2023
5
ILLIG, MICHAEL
TIFEC LLC • PRIVATE EQUITY
IndividualLEAWOOD, KS
$13,200
Nov 3, 2024
6
MADAY, GREG
SPECCHEM • CHAIRMAN CEO
IndividualMISSION HILLS, KS
$13,200
Nov 11, 2024
7
ILLIG, BONNE
RETIRED • RETIRED
IndividualLEAWOOD, KS
$6,600
Nov 2, 2024
8
ILLIG, AMY
HOMEMAKER • HOMEMAKER
IndividualLEAWOOD, KS
$6,600
Nov 12, 2024
9
MADAY, LIZ
SPECCHEM • DIRECTOR
IndividualMISSION HILLS, KS
$6,600
Nov 12, 2024
10
MAXWELL, KORB II
POLSINELLI • SHAREHOLDER
IndividualFAIRWAY, KS
$6,600
Nov 3, 2024

Sen. Hickenlooper, John W. [D-CO]

ID: H000273

Top Contributors

23

1
THE CHICKASAW NATION
OrganizationADA, OK
$1,300
Dec 12, 2023
2
THE CHICKASAW NATION
OrganizationADA, OK
$1,200
Dec 12, 2023
3
THE CHICKASAW NATION
OrganizationADA, OK
$900
Dec 31, 2023
4
ALLHASSANI, MEHDI
PALANTIR TECHNOLOGIES • OPERATIONS
IndividualPALO ALTO, CA
$3,300
Nov 25, 2023
5
SANKAR, SHYAM
PALANTIR TECHNOLOGIES • DIRECTOR
IndividualGREENWOOD VILLAGE, CO
$3,300
Nov 25, 2023
6
CARSON, RUSSELL
NOT EMPLOYED • NOT EMPLOYED
IndividualNEW YORK, NY
$3,300
Nov 17, 2023
7
SANKAR, SHYAM
PALANTIR TECHNOLOGIES • DIRECTOR
IndividualGREENWOOD VILLAGE, CO
$3,300
Nov 25, 2023
8
CARSON, RUSSELL
NOT EMPLOYED • NOT EMPLOYED
IndividualNEW YORK, NY
$3,300
Nov 17, 2023
9
GATES, WILLIAM H. III
BILL & MELINDA GATES FOUNDATION • PHILANTHROPIST
IndividualREDMOND, WA
$3,300
Oct 19, 2023
10
JAIN, AKASH
PALANTIR TECHNOLOGIES • EXECUTIVE
IndividualOAKLAND, CA
$3,300
Nov 26, 2023

Sen. Cortez Masto, Catherine [D-NV]

ID: C001113

Top Contributors

28

1
LAS VEGAS PAIUTE TRIBE
OrganizationLAS VEGAS, NV
$3,300
Nov 28, 2023
2
MISSISSIPPI BAND OF CHOCTAW INDIANS
OrganizationCHOCTAW, MS
$2,500
Dec 20, 2023
3
ALABAMA-COUSHATTA TRIBE
OrganizationLIVINGSTON, TX
$1,500
Oct 2, 2024
4
SHAKOPEE MDEWAKANTON SIOUX COMMUNITY
OrganizationPRIOR LAKE, MN
$1,000
Apr 26, 2024
5
SHAKOPEE MDEWAKANTON SIOUX COMMUNITY
OrganizationPRIOR LAKE, MN
$1,000
Jul 11, 2023
6
MUSCOGEE CREEK NATION
OrganizationOKMULGEE, OK
$1,000
Sep 18, 2024
7
MOHEGAN TRIBE OF INDIANS OF CONNECTICUT
OrganizationUNCASVILLE, CT
$1,000
Aug 12, 2024
8
CHOCTAW NATION OF OKLAHOMA
OrganizationDURANT, OK
$550
Oct 2, 2023
9
LONGTIN, LUANN
IndividualPOTOMAC, MD
$17,325
Jun 30, 2024
10
SLIFKA, ROSALYN
IndividualWALTHAM, MA
$5,800
Jun 30, 2024

Donor Network - Sen. Alsobrooks, Angela D. [D-MD]

PACs
Organizations
Individuals
Politicians

Hub layout: Politicians in center, donors arranged by type in rings around them.

Loading...

Showing 60 nodes and 60 connections

Total contributions: $60

Top Donors - Sen. Alsobrooks, Angela D. [D-MD]

Showing top 25 donors by contribution amount

4 Orgs3 Committees20 Individuals

Industry Impact

Which industries are materially affected by specific provisions in this bill. 3 helped.

  • Section 3(a) authorizes grants to States for programs to increase early detection and intervention for uterine fibroids, including screening procedures, patient navigation, and facilitating access to health care settings, which would benefit hospitals and health systems providing these services.

  • +Medical Devicesconfidence 0.85

    Section 3(b)(1) includes 'Screening procedures, including advanced gynecological imaging, including payment for such procedures,' which would increase demand for medical imaging devices used in uterine fibroid detection.

  • +Biotech & Researchconfidence 0.80

    Section 4 authorizes grants for research, including clinical trials, related to disparities in pain control and Asherman's Syndrome, which could benefit biotech firms engaged in uterine fibroid research and therapeutic development.

Who funds the sponsor on these industries

For each industry this bill affects, here's what the sponsor (Sen. Alsobrooks, Angela D. [D-MD])received from donors associated with that industry during the 2022–present cycles. Donations are not proof of intent — they are a record of who funds the people writing the law.

Industries this bill HELPS

  • from 112 contributions
    • ADAMS, GREG$3,300
    • BIEGELSEN, BETH$1,750
    • SIMON, BARRY$725
    • CHAPMAN, ANN PATTERSON$555
    • SONCEAU, CHERYL$500
  • from 29 contributions
    • MARINO, MICHAEL$3,300
    • SOBEL, SUZANNE$750
    • FONTENOT, JAMES$650
    • ARMBRUST, BRIAN$500
    • BROWN, ERIC$500
  • from 16 contributions
    • FLEMING, DENISE R$500
    • SHORTRIDGE, EMILY$275
    • BISHOP, CHAD$250
    • KEARSLEY, CROSBY$250
    • APFFEL, MICHAEL$200

Project 2025 Policy Matches

This bill shows semantic similarity to the following sections of the Project 2025 policy document.AI-enhanced analysis provides detailed alignment ratings.

Department of Health and Human Services

Weak
Vector: 65%
Pages: 533-535AI Enhanced

AI Analysis:

"The bill focuses on uterine fibroid research, awareness, and treatment access, while the Project 2025 HHS section emphasizes abortion restrictions, conscience protections, civil rights enforcement, and reproductive healthcare limitations—creating minimal thematic overlap despite both addressing women's health."

Key themes:women's healthhealthcare accessreproductive health

— 501 — Department of Health and Human Services 54. U.S. Department of Health and Human Services, Centers for Medicare and Medicaid Services, Office of Civil Rights, and Office of the Secretary, “Special Responsibilities of Medicare Hospitals in Emergency Cases and Discrimination on the Basis of Disability in Critical Health and Human Service Programs or Activities,” draft of Proposed Rule, January 14, 2021, https://www.hhs.gov/sites/default/files/infants-nprm.pdf (accessed March 17, 2023). 55. H.R. 26, Born-Alive Abortion Survivors Protection Act, 118th Congress, introduced January 9, 2023, https:// www.congress.gov/118/bills/hr26/BILLS-118hr26pcs.pdf (accessed March 17, 2023). 56. H.R. 7, No Taxpayer Funding for Abortion and Abortion Insurance Full Disclosure Act of 2023, 118th Congress, introduced January 9, 2023, https://www.congress.gov/118/bills/hr7/BILLS-118hr7ih.pdf (accessed March 17, 2023). 57. S. 401, Conscience Protection Act of 2021, 117th Congress, introduced February 24, 2021, https://www.congress. gov/117/bills/s401/BILLS-117s401is.pdf (accessed March 17, 2023). 58. U.S. Department of Health and Human Services, Centers for Medicare and Medicaid Services, and Office of the Secretary, “Nondiscrimination in Health Programs and Activities,” Notice of Proposed Rulemaking; Notice of Tribal Consultation, Federal Register, Vol. 87, No. 149 (August 4, 2022), pp. 47824–47920, https://www.govinfo. gov/content/pkg/FR-2022-08-04/pdf/2022-16217.pdf (accessed March 17, 2023). 59. Ibid., p. 47916. 60. The regulation was not finalized before the end of the Administration. U.S. Department of Agriculture, Food and Nutrition Services, “Revision of Categorical Eligibility in the Supplemental Nutrition Assistance Program (SNAP),” Proposed Rule, Federal Register, Vol. 84, No. 142 (July 24, 2019), pp. 35570–55581, https:// www.federalregister.gov/documents/2019/07/24/2019-15670/revision-of-categorical-eligibility-in-the- supplemental-nutrition-assistance-program-snap (accessed March 17, 2023). 61. 45 Code of Federal Regulations § 75.300(c) and (d), https://www.ecfr.gov/current/title-45/subtitle-A/ subchapter-A/part-75/subpart-D/subject-group-ECFR911e5e1a30bfbcb/section-75.300 (accessed March 17, 2023). 62. H.R. 1750, Child Welfare Provider Inclusion Act of 2021, 117th Congress, introduced March 10, 2021, https:// www.congress.gov/117/bills/hr1750/BILLS-117hr1750ih.pdf (accessed March 17, 2023), and S. 656, Child Welfare Provider Inclusion Act of 2021, 117th Congress, introduced March 10, 2021, https://www.congress.gov/117/bills/ s656/BILLS-117s656is.pdf (accessed March 17, 2023). 63. S. 3949, Trafficking Victims Protection Reauthorization Act of 2022, Public Law No. 117-348, 117th Congress, January 25, 2023, https://www.congress.gov/117/plaws/publ348/PLAW-117publ348.pdf (accessed March 17, 2023). 64. Kelsey Y. Santamaria, “Child Migrants at the Border: The Flores Settlement Agreement and Other Legal Developments,” Congressional Research Service In Focus No. IF11799, April 1, 2021, https://crsreports.congress. gov/product/pdf/IF/IF11799 (accessed March 17, 2023). 65. Report, Building a Happy Home: Marriage Education as a Tool to Strengthen Families, Social Capital Project Report No. 1-22, March 2022, p. 17, https://www.jec.senate.gov/public/_cache/files/3d102525-6f0d-48ed- 92f4-d71edd468ad6/building-a-happy-home.pdf (accessed March 17, 2023). The cover of the report reflects that the Social Capital Project is “[a] project of the Joint Economic Committee – Republicans.” 66. See, for example, Alan J. Hawkins, “Are Federally Supported Relationship Education Programs for Lower-Income Individuals and Couples Working? A Review of Evaluation Research,” American Enterprise Institute, September 2019, https://www. congress.gov/117/plaws/publ228/PLAW-117publ228.pdf (accessed March 17, 2023). 67. H.R. 8404, Respect for Marriage Act, Public Law No. 117-228, 117th Congress, December 13, 2022, https://www. congress.gov/117/plaws/publ228/PLAW-117publ228.pdf (accessed March 17, 2023). 68. Madison Marino, “Over 1,000 Safety Violations Mar Head Start. Children Deserve Better,” Heritage Foundation Commentary, November 10, 2022, https://www.heritage.org/education/commentary/over-1000-safety- violations-mar-head-start-children-deserve-better. 69. American Hospital Association v. Becerra, 596 U.S. ___ (2022), https://www.supremecourt.gov/ opinions/21pdf/20-1114_09m1.pdf (accessed March 17, 2023). 70. U.S. Department of the Treasury, Internal Revenue Service; U.S. Department of Labor, Employee Benefits Security Administration; and U.S. Department of Health and Human Services, Centers for Medicare and Medicaid Services, “Coverage of Certain Preventive Services Under the Affordable Care Act,” Notice of Proposed Rulemaking, Federal Register, Vol. 88, No. 22 (February 2, 2023), pp. 7236–7281, https://www. govinfo.gov/content/pkg/FR-2023-02-02/pdf/2023-01981.pdf (accessed March 17, 2023). — 502 — Mandate for Leadership: The Conservative Promise 71. 42 U.S. Code § 238n, https://www.law.cornell.edu/uscode/text/42/238n (accessed March 17, 2023). 72. U.S. Department of Health and Human Services, Health Resources and Services Administration, “Early Childhood Health,” last reviewed October 2022, https://mchb.hrsa.gov/programs-impact/focus-areas/early- childhood-health (accessed March 17, 2023). 73. American Pregnancy Association, “Having a Doula—What Are the Benefits?” https://americanpregnancy. org/healthy-pregnancy/labor-and-birth/having-a-doula/#:~:text=Other%20studies%20have%20shown%20 that%20having%20a%20doula,massage%20to%20reduce%20stress%20and%20anxiety%20during%20labor (accessed March 17, 2023). 74. S. 2372, VA MISSION [Maintaining Internal Systems and Strengthening Integrated Outside Networks] Act of 2018, Public Law No. 115-182, 115th Congress, June 6, 2018, https://www.congress.gov/115/plaws/publ182/ PLAW-115publ182.pdf (accessed March 17, 2023). 75. U.S. Department of Health and Human Services, “Securing Updated and Necessary Statutory Evaluations Timely,” Final Rule, Federal Register, Vol. 86, No. 11 (January 19, 2021), pp. 5694–5764, https://www.govinfo. gov/content/pkg/FR-2021-01-19/pdf/2021-00597.pdf (accessed March 22, 2023). 76. U.S. Department of Health and Human Services, Office of the Secretary, Office of the Assistant Secretary for Health, “Compliance with Statutory Program Integrity Requirements,” Final Rule, Federal Register, Vol. 84, No. 42 (March 4, 2029), pp. 7714–7791, https://www.govinfo.gov/content/pkg/FR-2019-03-04/pdf/2019-03461.pdf (accessed March 18, 2023). 77. U.S. Department of Health and Human Services, Office of the Secretary, Office of the Assistant Secretary for Health, “Ensuring Access to Equitable, Affordable, Client-Centered, Quality Family Planning Services,” Final Rule, Federal Register, Vol. 86, No. 192 (October 7, 2021), pp. 56144–56180, https://www.govinfo.gov/content/ pkg/FR-2021-10-07/pdf/2021-21542.pdf (accessed March 18, 2023). 78. S. 624, Title X Abortion Provider Prohibition Act, 118th Congress, introduced March 2, 2023, https://www. congress.gov/118/bills/s624/BILLS-118s624is.pdf (accessed March 18, 2023). 79. 50 U.S. Code Chapter 55, https://www.law.cornell.edu/uscode/text/50/chapter-55 (accessed March 22, 2023). 80. 18 U.S. Code § 13, https://www.law.cornell.edu/uscode/text/18/13 (accessed March 18, 2023). 81. Bowen v. American Hospital Association, 476 U.S. 610 (1986), https://tile.loc.gov/storage-services/service/ll/ usrep/usrep476/usrep476610/usrep476610.pdf (accessed 22, 2023). 82. U.S. Department of Health and Human Services, Office of the Secretary, “Notification of Interpretation and Enforcement of Section 1557 of the Affordable Care Act and Title IX of the Education Amendments of 1972,” Federal Register, Vol. 86, No. 99 (May 25, 2021), pp. 27984–27985, https://www.govinfo.gov/content/pkg/FR- 2021-05-25/pdf/2021-10477.pdf (accessed March 18, 2023). 83. U.S. Department of Health and Human Services, Office for Civil Rights, “HHS Notice and Guidance on Gender Affirming Care, Civil Rights, and Patient Privacy,” March 2, 2022, https://www.hhs.gov/sites/default/files/hhs- ocr-notice-and-guidance-gender-affirming-care.pdf (accessed March 18, 2023). 84. Heckler v. Chaney, 420 U.S. 821 (1985), https://caselaw.findlaw.com/us-supreme-court/470/821.html (accessed March 18, 2022). 85. U.S. Department of Health and Human Services, Office for Civil Rights, “Guidance to Nation’s Retail Pharmacies: Obligations Under Federal Civil Rights Laws to Ensure Access to Comprehensive Reproductive Health Care Services,” content last reviewed July 14, 2022, https://www.hhs.gov/civil-rights/for-individuals/ special-topics/reproductive-healthcare/pharmacies-guidance/index.html (accessed March 18, 2023). 86. H.R. 3103, “Health Insurance and Portability and Accountability Act of 1996, Public Law No. 104-191, 104th Congress, August 21, 1996, https://www.congress.gov/104/plaws/publ191/PLAW-104publ191.pdf (accessed March 18, 2023). 87. U.S. Department of Human Services, “HIPAA Privacy Rule and Disclosures of Information Relating to Reproductive Health Care,” content last reviewed June 29, 2022, (accessed March 18, 2023). See also “Protecting the Privacy and Security of Your Health Information When Using Your Personal Cell Phone or Tablet,” content last reviewed June 29, 2022, https://www.hhs.gov/hipaa/for-professionals/privacy/guidance/ cell-phone-hipaa/index.html (accessed March 18, 2023).

Department of Health and Human Services

Weak
Vector: 64%
Pages: 533-535AI Enhanced

AI Analysis:

"The bill focuses on uterine fibroid research, awareness, and treatment access, while the Project 2025 HHS section emphasizes Medicaid reform, abortion restrictions, conscience protections, and regulatory rollbacks—with no substantive overlap in goals or mechanisms."

Key themes:Department of Health and Human Serviceshealthcare accesswomen's health

— 500 — Mandate for Leadership: The Conservative Promise 32. Owcharenko Schaefer, “Medicaid at 55: Understanding the Design, Trends, and Reforms Needed to Improve the Health Care Safety Net.” 33. Brian Blase, “Managed Care in Medicaid: Need for Oversight, Accountability, and Reform,” Paragon Health Institute Policy Brief, October 13, 2022, https://paragoninstitute.org/wp-content/uploads/2022/10/20221012- Managed-Care-in-Medicaid-Need-for-Oversight-Accountability-and-Reform-FOR-DISTRIBUTION-V2.pdf (accessed February 13, 2023). 34. Owcharenko Schaefer, “Medicaid at 55: Understanding the Design, Trends, and Reforms Needed to Improve the Health Care Safety Net.” 35. 42 U.S. Code § 1315, https://www.law.cornell.edu/uscode/text/42/1315 (accessed March 17, 2023). 36. Chad D. Savage and Lee S. Gross, “Direct Primary Care: Update and Road Map for Patient-Centered Reforms,” Heritage Foundation Backgrounder No. 3635, June 28, 2021, https://www.heritage.org/sites/default/ files/2021-06/BG3635.pdf. 37. H.R. 133, Consolidated Appropriations Act, 2021, Public Law No. 116-260, 116th Congress, December 27, 2020, Division BB, Title I, https://www.congress.gov/116/plaws/publ260/PLAW-116publ260.pdf (accessed March 17, 2023). 38. Doug Badger, “On Surprise Medical Bills, Congress Should Side with Consumers, Not Special Interests,” Heritage Foundation Commentary, January 31, 2020, https://www.heritage.org/health-care-reform/ commentary/surprise-medical-bills-congress-should-side-consumers-not-special. 39. Edmund F. Haislmaier and Abigail Slagle, “Premiums, Choices, Deductibles, Care Access, and Government Dependence Under the Affordable Care Act: 2021 State-by-State Review,” Heritage Foundation Backgrounder No. 3668, November 2, 2021, https://www.heritage.org/sites/default/files/2021-11/BG3668.pdf. 40. U.S. Department of the Treasury, Internal Revenue Service; U.S. Department of Labor, Employee Benefits Security Administration; and U.S. Department of Health and Human Services, “Transparency in Coverage,” Final Rule, Federal Register, Vol. 85, No. 219 (November 12, 2020), pp. 72158–72310, https://www.govinfo.gov/ content/pkg/FR-2020-11-12/pdf/2020-24591.pdf (accessed March 17, 2023). 41. David N. Bernstein and Robert E. Moffit, “New Price Transparency Rule Will Help Transform America’s Health Care System,” Heritage Foundation Commentary, November 1, 2020, https://www.heritage.org/health-care- reform/commentary/new-price-transparency-rule-will-help-transform-americas-health-care. 42. Sluzala and Haislmaier, “Lessons from COVID-19: How Policymakers Should Reform the Regulation of Clinical Testing.” 43. Ibid. 44. Most recently enacted in H.R. 2471, Consolidated Appropriations Act, 2022, Public Law No. 117-103, 117th Congress, March 15, 2022, Division H, Title V, §§ 506–507, https://www.congress.gov/117/plaws/publ103/ PLAW-117publ103.pdf (accessed March 17, 2023). 45. President Joseph R. Biden Jr., Executive Order 14079, “Securing Access to Reproductive and Other Healthcare Services,” August 3, 2022, in Federal Register, Vol. 87, No. 154 (August 11, 2022), pp. 49505–49507, https:// www.govinfo.gov/content/pkg/FR-2022-08-11/pdf/2022-17420.pdf (accessed March 16, 2023). 46. Planned Parenthood, 2020–2021 Annual Report, p. 27, https://www.plannedparenthood.org/uploads/ filer_public/40/8f/408fc2ad-c8c2-48da-ad87-be5cc257d370/211214-ppfa-annualreport-20-21-c3-digital.pdf (accessed March 22, 2023). 47. Ibid., pp. 30 and 31. Total revenue of $1,714.4 million (p. 30) minus $1,580.7 million in total expenses (p. 31) yields $133,7 million. 48. Ibid., p. 28. 49. Ibid., p. 30. 50. H.R. 372, Protecting Life and Taxpayers Act of 2023, 118th Congress, introduced January 17, 2023, https://www. congress.gov/118/bills/hr372/BILLS-118hr372ih.pdf (accessed March 17, 2023). 51. 42 U.S. Code § 18023, https://www.law.cornell.edu/uscode/text/42/18023 (accessed March 17, 2023). 52. H.R. 3128, Consolidated Omnibus Budget Reconciliation Act of 1985, Public Law No. 99-272, 99th Congress, April 7, 1986, Title IX, Subtitle A, Part 1, Subpart B, § 9121, https://www.congress.gov/99/statute/STATUTE-100/ STATUTE-100-Pg82.pdf (accessed March 17, 2023). 53. H.R. 8070, Rehabilitation Act of 1973, Public Law No. 93-112, 93rd Congress, September 26, 1973, https://www. congress.gov/93/statute/STATUTE-87/STATUTE-87-Pg355.pdf (accessed March 17, 2023). — 501 — Department of Health and Human Services 54. U.S. Department of Health and Human Services, Centers for Medicare and Medicaid Services, Office of Civil Rights, and Office of the Secretary, “Special Responsibilities of Medicare Hospitals in Emergency Cases and Discrimination on the Basis of Disability in Critical Health and Human Service Programs or Activities,” draft of Proposed Rule, January 14, 2021, https://www.hhs.gov/sites/default/files/infants-nprm.pdf (accessed March 17, 2023). 55. H.R. 26, Born-Alive Abortion Survivors Protection Act, 118th Congress, introduced January 9, 2023, https:// www.congress.gov/118/bills/hr26/BILLS-118hr26pcs.pdf (accessed March 17, 2023). 56. H.R. 7, No Taxpayer Funding for Abortion and Abortion Insurance Full Disclosure Act of 2023, 118th Congress, introduced January 9, 2023, https://www.congress.gov/118/bills/hr7/BILLS-118hr7ih.pdf (accessed March 17, 2023). 57. S. 401, Conscience Protection Act of 2021, 117th Congress, introduced February 24, 2021, https://www.congress. gov/117/bills/s401/BILLS-117s401is.pdf (accessed March 17, 2023). 58. U.S. Department of Health and Human Services, Centers for Medicare and Medicaid Services, and Office of the Secretary, “Nondiscrimination in Health Programs and Activities,” Notice of Proposed Rulemaking; Notice of Tribal Consultation, Federal Register, Vol. 87, No. 149 (August 4, 2022), pp. 47824–47920, https://www.govinfo. gov/content/pkg/FR-2022-08-04/pdf/2022-16217.pdf (accessed March 17, 2023). 59. Ibid., p. 47916. 60. The regulation was not finalized before the end of the Administration. U.S. Department of Agriculture, Food and Nutrition Services, “Revision of Categorical Eligibility in the Supplemental Nutrition Assistance Program (SNAP),” Proposed Rule, Federal Register, Vol. 84, No. 142 (July 24, 2019), pp. 35570–55581, https:// www.federalregister.gov/documents/2019/07/24/2019-15670/revision-of-categorical-eligibility-in-the- supplemental-nutrition-assistance-program-snap (accessed March 17, 2023). 61. 45 Code of Federal Regulations § 75.300(c) and (d), https://www.ecfr.gov/current/title-45/subtitle-A/ subchapter-A/part-75/subpart-D/subject-group-ECFR911e5e1a30bfbcb/section-75.300 (accessed March 17, 2023). 62. H.R. 1750, Child Welfare Provider Inclusion Act of 2021, 117th Congress, introduced March 10, 2021, https:// www.congress.gov/117/bills/hr1750/BILLS-117hr1750ih.pdf (accessed March 17, 2023), and S. 656, Child Welfare Provider Inclusion Act of 2021, 117th Congress, introduced March 10, 2021, https://www.congress.gov/117/bills/ s656/BILLS-117s656is.pdf (accessed March 17, 2023). 63. S. 3949, Trafficking Victims Protection Reauthorization Act of 2022, Public Law No. 117-348, 117th Congress, January 25, 2023, https://www.congress.gov/117/plaws/publ348/PLAW-117publ348.pdf (accessed March 17, 2023). 64. Kelsey Y. Santamaria, “Child Migrants at the Border: The Flores Settlement Agreement and Other Legal Developments,” Congressional Research Service In Focus No. IF11799, April 1, 2021, https://crsreports.congress. gov/product/pdf/IF/IF11799 (accessed March 17, 2023). 65. Report, Building a Happy Home: Marriage Education as a Tool to Strengthen Families, Social Capital Project Report No. 1-22, March 2022, p. 17, https://www.jec.senate.gov/public/_cache/files/3d102525-6f0d-48ed- 92f4-d71edd468ad6/building-a-happy-home.pdf (accessed March 17, 2023). The cover of the report reflects that the Social Capital Project is “[a] project of the Joint Economic Committee – Republicans.” 66. See, for example, Alan J. Hawkins, “Are Federally Supported Relationship Education Programs for Lower-Income Individuals and Couples Working? A Review of Evaluation Research,” American Enterprise Institute, September 2019, https://www. congress.gov/117/plaws/publ228/PLAW-117publ228.pdf (accessed March 17, 2023). 67. H.R. 8404, Respect for Marriage Act, Public Law No. 117-228, 117th Congress, December 13, 2022, https://www. congress.gov/117/plaws/publ228/PLAW-117publ228.pdf (accessed March 17, 2023). 68. Madison Marino, “Over 1,000 Safety Violations Mar Head Start. Children Deserve Better,” Heritage Foundation Commentary, November 10, 2022, https://www.heritage.org/education/commentary/over-1000-safety- violations-mar-head-start-children-deserve-better. 69. American Hospital Association v. Becerra, 596 U.S. ___ (2022), https://www.supremecourt.gov/ opinions/21pdf/20-1114_09m1.pdf (accessed March 17, 2023). 70. U.S. Department of the Treasury, Internal Revenue Service; U.S. Department of Labor, Employee Benefits Security Administration; and U.S. Department of Health and Human Services, Centers for Medicare and Medicaid Services, “Coverage of Certain Preventive Services Under the Affordable Care Act,” Notice of Proposed Rulemaking, Federal Register, Vol. 88, No. 22 (February 2, 2023), pp. 7236–7281, https://www. govinfo.gov/content/pkg/FR-2023-02-02/pdf/2023-01981.pdf (accessed March 17, 2023).

Department of Health and Human Services

Weak
Vector: 63%
Pages: 491-493AI Enhanced

AI Analysis:

"Both the bill and the Project 2025 HHS section involve HHS-led initiatives to improve women's health and support research, but the bill targets uterine fibroid detection and treatment while the Project 2025 policy focuses on abortion pill restrictions, vaccine importation, and bioethics reforms, resulting only in tangential overlap."

Key themes:women's healthHHS authorityresearch fundinghealth disparities

— 459 — Department of Health and Human Services pro-life states that are trying to protect women, girls, and unborn children from abortion. The FDA should therefore: l Reinstate earlier safety protocols for Mifeprex that were mostly eliminated in 2016 and apply these protocols to any generic version of mifepristone. A bare-minimum policy of limiting abortion pills to the pre-2016 policy of 49 days gestation, returning to the pre-2021 in-person dispensing requirement, and returning to requiring prescribers to report all serious adverse events, not just deaths, to the drug sponsor would increase women’s health and safety. l Address weaknesses in the current FAERS (FDA Adverse Events Reporting System). The Administration and policymakers should ensure that health care workers, particularly those in hospitals and emergency rooms, report abortion pill complications. Women who experience complications from abortion pills typically go to an emergency room, not to the abortion pill prescriber, so putting the onus of reporting on the prescriber who typically has no idea that a complication has occurred means that the FAERS is seriously undercounting adverse events. Submitting an adverse event to the database should be a quick and efficient process for busy health care practitioners. Currently, providers report that the process is difficult and convoluted. l Implement a policy of transparency about inspections of the abortion pill’s sponsors, Danco and GenBioPro, as well as facilities that manufacture the pills. The FDA should respond to congressional requests and Freedom of Information Act (FOIA) requests about inspections, compliance, and post-marketing safety in a timely manner. l Stop promoting or approving mail-order abortions in violation of long-standing federal laws that prohibit the mailing and interstate carriage of abortion drugs.16 Vaccine Importation. Thousands of Americans of faith and conscience wish to receive various childhood vaccinations for themselves and their families but are not allowed to receive vaccines that are derived through or tested on aborted fetal cells. For example, the chickenpox, Hepatitis, and MMR vaccines in the U.S. are all linked to abortion in this way. There are ethically derived alternatives abroad that have been used safely there for decades, but the FDA makes it exceedingly difficult for Americans to import them. In January 2021, the HHS Office for Civil Rights (OCR) and the FDA jointly announced that HHS was required by the Religious Freedom Restoration Act — 460 — Mandate for Leadership: The Conservative Promise (RFRA)17 to allow bulk importation by doctors of certain Japanese-made vaccines to accommodate religious needs of patients, but the Biden FDA unlawfully revoked this waiver. The FDA should restore the waiver to comply with RFRA and for the obvious public health benefits of increased childhood vaccination by families seek- ing ethically derived alternatives. To avoid future moral coercion of the sort experienced with the COVID-19 vac- cines, the FDA and NIH should require the development of drugs and biologics that are free from moral taint and switch to cell lines that are not derived from aborted fetal cell lines or aborted baby body parts. Conflicts of Interest. A 2018 report in Science found that more than two-thirds of FDA reviewers later ended up at the same companies whose products they had been reviewing while they were working for the government.18 This revolving door is one mechanism by which pharmaceutical companies capture the agencies that regulate them. The FDA should impose a lengthy cooling off period for reviewers, preventing them from working for companies they regulated. In 1997, the FDA relaxed regulations to permit broadcast drug advertisements, after which Big Pharma began routine direct-to-consumer advertising, making the United States and New Zealand the only countries where such practices are legal. Following the 1997 changes, pharma became the largest advertiser for all major media organizations. This buys considerable influence in the newsroom—whether media companies acknowledge this or not—and distorts independent reporting on public health issues. The FDA or Congress should regulate where and how paid advertising is used by pharmaceutical companies more stringently, especially on media outlets. NATIONAL INSTITUTES OF HEALTH (NIH) The National Institutes of Health (NIH) is the world’s largest biomedical research agency and is made up of 27 different components called Institutes and Centers. Despite its popular image as a benign science agency, NIH was respon- sible for paying for research in aborted baby body parts, human animal chimera experiments, and gain-of-function viral research that may have been responsible for COVID-19. Bioethics Reform. Research using fetal tissue obtained from elective abortions is immoral and obsolete. Research using human embryonic stem cells also involves the destruction of human life and should not be subsidized with taxpayer dollars. Good science and life-affirming, ethical research are not mutually exclusive. In fact, ethically derived sources such as discarded surgical tissue and adult stem cells (made pluripotent), not tissue obtained from elective abortions, have contributed the most successful treatments for a variety of ailments. Congress authorized HHS to choose not to fund extramural abortion-de- rived fetal tissue research that fails ethics advisory board review, and in 2019, the

Showing 3 of 5 policy matches

About These Correlations

Policy matches are calculated using a hybrid approach: initial candidates are found using semantic similarity between bill summaries and Project 2025 policy text, then an AI model (Llama 3.1 70B) provides detailed alignment ratings and analysis. Ratings range from 1 (minimal alignment) to 5 (very strong alignment). This analysis does not imply direct causation or intent.

Full Policy Text

Related Bills